CompletedNCT03826875
Preventing Depression After Aneurysmal Brain Bleeding
About this title
Read the official source — NCT03826875Medication studyAges 18–85United States
Understand this study
Who was this study for?
This study was for people with depression. Listed age limits: 18 years to 85 years. Other eligibility criteria applied.
What did participation involve?
Depending on the group, the protocol specifies the study medication (fluoxetine) or a placebo (an inactive comparison treatment).
- Listed locations
- SeattleSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: March 1, 2019
- Recruitment status
- Completed
- Enrollment listed in the registry
- 8
- Sponsor
- University of Washington
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 85 Years
- Official registry ID
- NCT03826875
- Official title
Show the full official title
Preventative Treatment of Depression in Survivors of Aneurysmal Subarachnoid Hemorrhage
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Seattle
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Washington, a university.
Did this study involve medication?
Yes. The study involved medication, including Fluoxetine and Placebo.
Who was this study for?
This study was for people with depression. Listed age limits: 18 years to 85 years. Other eligibility criteria applied.
